SHANGHAI, China, Nov. 3 /Xinhua-PRNewswire/ -- Piper Jaffray will host
its first China Life Sciences Event on Wednesday, Nov. 15 in Shanghai. The
event is co-hosted by O'Melveny & Myers LLP and Deloitte Touche.
The China Life Sciences Event, which showcases some of the most
innovative companies in the life sciences sector, will provide investors and
corporate executives a unique venue in which to hear first-hand about
prospects, opportunities, risks and challenges in this growing health-related
market segment.
The conference agenda includes presentation topics covering the growth of
life sciences companies, attractive opportunities for institutional
investors, pertinent considerations for companies in this sector and the
changing life sciences climate in China.
Keynote addresses will be presented by Gerald Chan, chairman of the
Morningside Group and Ren Dequan, former deputy commissioner of the State
Food and Drug Administration (SFDA). Other presentations will highlight
perspectives from venture and private equity investors, an analysis of the
U.S. capital markets and updates from biopharmaceutical and medical device
company executives. Additional topics will include: intellectual property
protection and enforcement, the regulatory approval process, strategic
alliances and strategies for mergers and acquisitions.
Companies scheduled to participate in the China Life Sciences Event
include: Aura Partners, BioVeda Capital, Bridge Pharmaceuticals, Capital
BioChip, China Medipharm, China Medical, ChongQing JingShan, Curis, Eli Lily,
Fidelity Ventures, Green Valley, Hutchinson MediPharma Limited, IDG
Technology Venture Investment, Lifetech Scientific, Medsphere, Microport
Medical Co., Ltd., Morningside Group, Otsuka China, Pfizer, Profex, SAIF
Partners, SIG Capital Limited, Simcere Pharmaceuticals, Sinocro Partners
Limited, Summit Life Sciences, Sunway Biotech Co., Ltd., TongJiTang and WI
Harper Group.
Company and investor participation in the China Life Sciences Event is by
invitation only. Piper Jaffray clients interested in attending should contact
their Piper Jaffray representative.
About Piper Jaffray
Piper Jaffray Companies is a leading, international middle market
investment bank and institutional securities firm, serving the needs of
middle market corporations, private equity groups, public entities, nonprofit
clients and institutional investors. Founded in 1895, Piper Jaffray provides
a comprehensive set of products and services, including equity and debt
capital markets products; public finance services; mergers and acquisitions
advisory services; high-yield and structured products; institutional equity
and fixed-income sales and trading; and equity and high-yield research. With
headquarters in Minneapolis, Piper Jaffray has 25 offices across the United
States and international locations in London, Madrid and Shanghai. The
firm's UK operating subsidiary, Piper Jaffray Ltd., is authorized and
regulated by the Financial Services Authority and is a member of the London
Stock Exchange. Piper Jaffray & Co. is the firm's principal operating
subsidiary. (NYSE: PJC) ( http://www.piperjaffray.com )
Since 1895. Member SIPC and NYSE.
